Director · Annovis Bio, Inc. · Annovis Bio, Inc. — Warrants
Side
BUY
Value
—
Shares
5.00M
Price
—
Executed
Nov 6, 2026
Disclosed
Nov 6, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Nov 6 executedNov 6, 2026 disclosed
ANVS · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Hoffman Michael B filed this Form 4 reporting a open-market purchase of ANVS on Nov 6, 2026. It became public on Nov 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Hoffman Michael Bcik:0001290208
Issuer
Annovis Bio, Inc.cik:0001477845
Revision history · 0
No field has changed since this record was first ingested.
